share_log

Esperion Therapeutics | 8-K: Esperion Reports First Quarter 2024 Financial Results

SEC announcement ·  May 7 07:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more